Immunohistochemical Double-hit Score Is as Strong Predictor of Outcome In Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide. Doxorubicine, Vincristine, and Prednisone.

Tina Marie Green; Ken H. Young; Carlo  Visco; Zijun Y. Xu-Monette; Attilo Orazi; Ronald S. Go; Ole Nielsen; Ole V. Gadeberg; Torben  Mourits-Andersen; Mikael Frederiksen; Lars Møller Pedersen; Michael Boe Møller

Immunohistochemical Double-hit Score Is as Strong Predictor of Outcome In Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide. Doxorubicine, Vincristine, and Prednisone.

Tina Marie Green, Ken H. Young, Carlo Visco, Zijun Y. Xu-Monette, Attilo Orazi, Ronald S. Go, Ole Nielsen, Ole V. Gadeberg, Torben Mourits-Andersen, Mikael Frederiksen, Lars Møller Pedersen, Michael Boe Møller

Research output: Contribution to journal › Journal article › Research › peer-review

Original language	English
Journal	Journal of Clinical Oncology
Volume	30
Issue number	28
Pages (from-to)	3460-3467
Number of pages	8
ISSN	0732-183X
Publication status	Published - 2012

Cite this

Green, T. M., Young, K. H., Visco, C., Xu-Monette, Z. Y., Orazi, A., Go, R. S., Nielsen, O., Gadeberg, O. V., Mourits-Andersen, T., Frederiksen, M., Pedersen, L. M., & Møller, M. B. (2012). Immunohistochemical Double-hit Score Is as Strong Predictor of Outcome In Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide. Doxorubicine, Vincristine, and Prednisone. Journal of Clinical Oncology, 30(28), 3460-3467.

@article{dd625b26e0184e85a3209bf9c277b80c,

title = "Immunohistochemical Double-hit Score Is as Strong Predictor of Outcome In Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide. Doxorubicine, Vincristine, and Prednisone.",

author = "Green, {Tina Marie} and Young, {Ken H.} and Carlo Visco and Xu-Monette, {Zijun Y.} and Attilo Orazi and Go, {Ronald S.} and Ole Nielsen and Gadeberg, {Ole V.} and Torben Mourits-Andersen and Mikael Frederiksen and Pedersen, {Lars M{\o}ller} and M{\o}ller, {Michael Boe}",

year = "2012",

language = "English",

volume = "30",

pages = "3460--3467",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "28",

}

Green, TM, Young, KH, Visco, C, Xu-Monette, ZY, Orazi, A, Go, RS, Nielsen, O, Gadeberg, OV, Mourits-Andersen, T, Frederiksen, M, Pedersen, LM & Møller, MB 2012, 'Immunohistochemical Double-hit Score Is as Strong Predictor of Outcome In Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide. Doxorubicine, Vincristine, and Prednisone.', Journal of Clinical Oncology, vol. 30, no. 28, pp. 3460-3467.

Immunohistochemical Double-hit Score Is as Strong Predictor of Outcome In Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide. Doxorubicine, Vincristine, and Prednisone. / Green, Tina Marie; Young, Ken H.; Visco, Carlo et al.
In: Journal of Clinical Oncology, Vol. 30, No. 28, 2012, p. 3460-3467.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Immunohistochemical Double-hit Score Is as Strong Predictor of Outcome In Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide. Doxorubicine, Vincristine, and Prednisone.

AU - Green, Tina Marie

AU - Young, Ken H.

AU - Visco, Carlo

AU - Xu-Monette, Zijun Y.

AU - Orazi, Attilo

AU - Go, Ronald S.

AU - Nielsen, Ole

AU - Gadeberg, Ole V.

AU - Mourits-Andersen, Torben

AU - Frederiksen, Mikael

AU - Pedersen, Lars Møller

AU - Møller, Michael Boe

PY - 2012

Y1 - 2012

M3 - Journal article

SN - 0732-183X

VL - 30

SP - 3460

EP - 3467

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 28

ER -